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Abstract
Background: Cell surface glycosylation patterns are markers of cell type and status. However, the mechanisms regulating
surface glycosylation patterns remain unknown.
Methodology/Principal Findings: Using a panel of carbohydrate surface markers, we have shown that cell surface sialylation
and fucosylation were downregulated in L1
2/y neurons versus L1
+/y neurons. Consistently, mRNA levels of sialyltransferase
ST6Gal1, and fucosyltransferase FUT9 were significantly reduced in L1
2/y neurons. Moreover, treatment of L1
+/y neurons with
L1 antibodies, triggering signal transduction downstream of L1, led to an increase in cell surface sialylation and fucosylation
compared to rat IgG-treated cells. ShRNAs for both ST6Gal1 and FUT9 blocked L1 antibody-mediated enhancement of neurite
outgrowth, cell survival and migration. A phospholipase Cc (PLCc) inhibitor and shRNA, as well as an Erk inhibitor, reduced
ST6Gal1 and FUT9 mRNA levels and inhibited effects of L1 on neurite outgrowth and cell survival.
Conclusions: Neuronal surface sialylation and fucosylation are regulated via PLCc by L1, modulating neurite outgrowth, cell
survival and migration.
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Introduction
Glycosylation of proteins and lipids is a primeexample of a cellular
process that is not under the direct control of the genome. This
contributes to the functional diversity required to generate extensive
phenotypes from a limited genotype [1]. Glycosylation is a crucial
post- or co-translational modification of more than 50% of all
eukaryotic proteins according to database analyses [2]. It is affected
by a multitude of factors, such as cellular metabolism and the rate of
cell growth. Accumulated evidence indicates that glycan structures
play important roles in various contexts, including differentiation,
development, fertilization, inflammation, and cell–cell recognition
[3,4]. Glycosylation defects in mice and their links to the development
of diseases have shown that the mammalian glycome contains a
significant amount of biological information [5,6]. Moreover, defects
in glycosylation pathways are often associated with psychomotor/
mental retardation or other neuropathological symptoms as seen in
mostcongenitaldiseasesofglycosylation[7].Itisbelievedthatspecific
glycosylation patterns are expressed in a cell type-specific and
developmentally regulated manner. Thus, identification of the
molecular mechanisms underlying regulation of glycan diversity will
help to elucidate how an ensemble of glycans displayed at the cell
surface governs signal transduction and cell–cell communication via
multivalent interactions with proteins.
Fucose is one of the most important glycans expressed at the cell
surface. It is a deoxyhexose that is present in a wide variety of
organisms. In mammals, fucosylated carbohydrate structures have
important roles in a variety of biological and pathological
processes, such as tissue development, angiogenesis, fertilization,
selectin-mediated leukocyte-endothelial adhesion, inflammation,
host immune response, and tumor metastasis, including Notch
receptor family signaling events [8]. Alterations in the expression
of fucosylated oligosaccharides occur in several pathological
processes, including cancer and atherosclerosis [8]. Fucosylated
glycans are generated by fucosyltransferases (FucTs) that are
responsible for the catalysis of fucose transfer from the donor
guanosine-diphosphate fucose (GDP-fucose) to various acceptor
molecules including oligosaccharides, glycoproteins, and glycolip-
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outside the nervous system is determined by carbohydrate-
dependent signal transduction between cell surface recognition
molecules as elegantly shown for Notch and its cell surface binding
partners Jagged/Serrate and Delta. Ligand-receptor interaction
between these molecules is determined by the O-fucose-b1,3-N-
acetylglucosaminyl-transferase, Fringe, which determines the
Notch-bearing cell’s reaction to its binding partners [10]. These
examples highlight the importance of carbohydrates in cell–cell
interactions outside the nervous system.
Another very important monosaccharideis sialicacid.Sialicacids
are expressed as terminal sugars with a shared nine-carbon
backbone in several classes of cell surface and secreted glycan
molecules [4]. Sialic acids provide negative charge and hydrophi-
licity to vertebrate cell surfaces, mask subterminal galactose residues
from recognition by certain receptors, and act as receptors for
pathogens and toxins [4], In particular, sialic acids play an
important role during mammalian development [11]. In the
nervous system, polysialic acid is nearly exclusively carried by the
neural cell adhesion molecule (NCAM), a protein belonging to the
immunoglobulin (Ig) superfamily. Polysialylated NCAM is involved
in the development of the nervous system, N-methyl-D-aspartate
(NMDA) receptor-dependent synaptic plasticity, and regeneration
in the adult [7]. Several vertebrate proteins have been found that
mediate specific recognition events involving sialic acids [4], such as
the cell recognition molecule L1, another Ig superfamily member,
that specifically recognizes 2,3-linked sialic acids present on the
heavily glycosylated cell surface protein, CD24 [7,12].
L1 itself is one of many carbohydrate-carrying molecules in the
nervous system, where it is widely expressed and involved in many
aspects of neural development, regeneration and synaptic plasticity
in the adult [13]. Various human genetic disorders with prominent
nervous system defects are caused by mutations in L1 [14]. Cell
recognition molecules at the cell surface are not only donors, but
also acceptors of carbohydrates. These carbohydrates mediate
interactions between recognition molecules in cis or trans and
thereby modulate their functions as receptors at the cell surface
and as signal transducers [7]. Modulation of these interactions
occurs through finely tuned synthesis of glycan chains depending
on the neural cell type and its developmental state. However, it is
unknown whether these cell recognition molecules are also
involved in regulation of glycan diversity at the cell surface.
Lectins are proteins which recognize specific glycan structures.
Due to this property, they have been extremely useful in studying
glycan variation [15,16]. Glycans and lectins usually interact with
lower affinities than those found for protein-protein interactions.
However, lectin-glycan interactions are characterized by a
significant avidity given that most lectins can bind multiple glycan
moieties and do so with considerable specificity. Taking advantage
of this, in the present study, we have used lectins and
carbohydrate-specific antibodies to investigate the changes in
glycosylation patterns on cell surfaces of neurons stimulated with
L1 antibodies. We have demonstrated that L1 plays a role in
modulating both sialylation and fucosylation at cell surfaces
through increased expression of both ST6Gal1 and FUT9 via a
phospholipase Cc-mediated mechanism by which it enhances
neurite outgrowth, cell survival and migration of neurons.
Materials and Methods
Antibodies, lectins and inhibitors
Goat polyclonal anti-mouse, rat and human FUT9 antibodies
were purchased from Santa Cruz Biotechnology, Inc. (Santa Cruz,
CA, USA). Mouse monoclonal anti-human ST6Gal1 antibody was
purchased from Chemicon International, Inc. (Temecula, CA,
USA). Rabbit polyclonal anti-mouse, rat and human PLCc
antibodies were purchased from Cell Signaling Technology, Inc.
(Danvers, MA, USA). The monoclonal anti-mouse L1 antibody
557 was produced and purified as previously described [17]. L3,
L4 and L5 antibodies were produced as previously described
[18,19,20,21]. Biotinylated lectins were purchased from Vector
Laboratories, Inc. (Burlingame, CA, USA). R-Phycoerythin (R-
PE)-conjugated mouse anti-rat monoclonal, PerCP-CY5.5-conju-
gated rat anti-mouse IgM monoclonal and R-PE-conjugated rat
anti-mouse IgM monoclonal antibodies were purchased from BD
Biosciences (Franklin Lakes, NJ, USA). Inhibitors were either from
Calbiochem, San Diego, CA, USA (U73122, Cdc25 phosphatase
inhibitor II, and Erk inhibitor) or from Sigma, St. Louis, MO,
USA (LY294002 and KT5720).
Mice
For primary culture of cerebellar granule neurons, we used L1-
deficient mice (129x1SvJL1/tTA L1
2/y, abbreviated line name:
L1ki129) and wild-type littermates (129x1SvJL1/tTA L1
+/y). In
L1 deficient mice, the expression of L1 was completely abolished
by insertion of a tetracycline-controlled transactivator into the
second exon of the L1 gene [22]. L1
2/y mice and L1
+/y mice were
generated from the mating of 129x1SvJ males and L1ki129
heterozygous females. The experiments involving animals were
approved by the Institutional Animal Care and Use Committee
(IACUC) of Singapore General Hospital.
Cell culture
All cell culture reagents were purchased from Invitrogen Life
Technologies (Merelbeke, Belgium) unless indicated otherwise.
Dissociated cerebellar granule neurons were obtained by sediment-
ing trypsinized cerebellar cells from 6- to 8-day-old mice through a
Percoll gradient [23]. The neuronal cell suspension was seeded on
poly-L-lysine (Sigma; Mr 70,000–150,000)-coated culture dishes
and maintained in chemically defined serum-free medium contain-
ing basal medium Eagle’s supplemented with 2 mM L-glutamine,
1 mg/mL bovine serum albumin, 12.5 mg/mL insulin, 4 nM
thyroxine, 100 mg/mL transferrin, 30 nM sodium selenite,
0.1 mg/mL streptomycin and 10 U/mL penicillin in a 5% CO2
incubator at 37uC. The monoclonal L1 antibody was produced and
purified as previously described [17]. Non-immune rat IgG served
as a negative control. After treating with L1 antibody or rat IgG
(control) for 24 h, neurons were dissociated with 0.05% trypsin/
0.04% EDTA to single cells for assay by flow cytometry. NIH3T3
cells were maintained in DMEM supplemented with 10% FBS,
0.5 U/mL penicillin, 0.5 U/mL streptomycin. Cells were passaged
every 2 or 3 days using 0.05% trypsin/0.04% EDTA. The single
cells obtained were used for assay by flow cytometry.
Flow cytometric analysis of surface expression of
carbohydrates
Cell surface carbohydrate expression was assessed by indirect
immunofluorescence detection using a flow cytometer, FACSCa-
libur (Becton-Dickinson, San Jose, CA, USA) equipped with an
argon laser with an emission wavelength at 488 nm. CellQuest Pro
software (Becton-Dickinson) was used for cell acquisition and
analysis. Cerebellar neurons were prepared and cultured as
described above. The cells were digested with 0.05% trypsin and
washed twice with PBS (Gibco, Long Island, NY, USA). Single cell
suspension was prepared in PBS with 10% FBS with the
concentration adjusted to 10
7 cells/ml for indirect antibody
labeling. Antibody labelings of the cells were carried out using 4 ml
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suspension (5.0610
5 cells) was aliquoted into 4 ml sterile centrifuge
tubes (Falcon) and incubated with primary antibody or lectin
(1 mg) targeting one of 14 cell surface carbohydrates in PBS with
10% FBS for 30 minutes at 4uC in the darkness. Cells were
washed 3 times with chilled PBS and then incubated with
secondary antibody conjugated with R-phycoerythin or Peridinin
chlorophyll protein (R-PE or Per-CP, 1 mg) in 50 ml of PBS with
10% FBS for a further 30 minutes at 4uC in the dark. Cells were
washed 3 times with chilled PBS, fixed in PBS with 1%
formaldehyde (Sigma, St. Louis, USA) and kept at 4uCi n
darkness before flow cytometric analysis. 10
4 cells from each tube
were acquired for analysis. Unstained cells and cells incubated
with secondary antibody alone were used as controls for
autofluorescence.
Microarray analysis
Procedures for cDNA synthesis, labeling, and hybridization
were carried out in accordance with the manufacturer’s protocol
(Affymetrix Inc., Santa Clara, CA, USA). All experiments were
performed using Affymetrix mouse genome Genechip 430 2.0
array and MOE 430 A array. Briefly, 15 mg total RNA was used
for first strand cDNA synthesis with a high-performance liquid
chromatography purified T7-(dT) 24 primer. Synthesis of biotin
labeled cRNA was carried out using the ENZO RNA transcript
labeling kit (Affymetrix). For hybridization, 15 mg fragmented
cRNA was incubated with the chip in 200 ml hybridization
solution in a Hybridization Oven 640 (Affymetrix) at 45uC for
16 hours. Genechips were washed and stained with streptavidin-
phycoerythrin using the microfluidic workstation
TM (Affymetrix)
and scanned with Affymetrix Microarray scanner system. Data
were analyzed using Spotfire software (Somerville, MA, USA).
Real-time PCR
To compare the transcript levels, total RNA from neurons was
isolated using an RNeasy mini kit (Qiagen, Valencia, CA, USA).
Total RNA concentration was determined using a spectropho-
tometer to measure absorptions at 260 nm and 280 nm
wavelengths. To check RNA integrity, total RNA was separated
in a 1% agarose gel containing formaldehyde and stained with
ethidium bromide. Reverse transcription was performed with the
SuperScript
TM First-strand Synthesis System for RT-PCR Kit
(Invitrogen, Carlsbad, CA), in accordance with the manufacturer’s
protocol. Briefly, 5 mg total RNA was reverse transcribed with
random hexamers. First-strand reverse transcribed cDNA was
then diluted 1:10 in water before use for real-time PCR. cDNA
was subjected to real-time PCR using the 7000 ABI Detection
System (Applied Biosystems, Foster City, CA, USA). Real-time
PCR reactions (Applied Biosystems, California, USA) included 16
TaqMan Universal PCR master mix, 16Assays-on-Demand TM
Gene Expression Assay Mix, and 2 ml of template in a 20 ml
reaction volume. The following program was run: 50uC for
30 min, 95uC for 15 min, then 40 cycles of 94uC for 15 sec, 60uC
for 1 min, followed by plate reading. The assay ID number of Fut9
is Mm01223272_m1; the assay ID number of St6gal1 is
Mm00486119_m1. Gapdh was used as a reference, and its assay
ID number is Mn99999915_g1.
Neurite outgrowth assay
Diethyl ether-cleaned glasscoverslips were coated overnight at 4uC
with poly-L-lysine (100 mg/mL in distilled water) and washed three
times with distilled water. Purified cerebellar granule neurons from
cerebella of 6- to 8-day-old mice were seeded onto the coverslips
(1610
5cells/mL) and allowed one hour to adhere. Subsequently,
different concentrations of anti-L1 antibody 557 or equimolar
amounts of rat IgG were added. After cultivation for 24 hours, the
cells were fixed for one hour by adding 4% paraformaldehyde and
stained with Coomassie brilliant blue (0.2%) for 30 minutes at room
temperature. Coomassie brilliant blue-stained cultures were analyzed
by evaluating the length of individual neurites. Only neurites that did
not contact other cells or neurites and had a length of at least one cell
diameter were measured [14]. For each cell measured, the total
length of all neurites and the length of the longest neurite were
determined. For each experimental condition, at least three
independent experiments were performed in duplicate and more
than 120 neurites were measured (30 neurites/coverslip) with LSM
Image Browser System. Non-immune rat IgG treatment was used as
an e g a t i v ec o n t r o l .
Migration assay
Costar transwell polycarbonate filters (5.0 mm pore size) were
used in the migration assay [24]. The undersurfaces of the 6.5 mm
transwell membranes were coated with anti-L1 antibody in PBS
(200 mg/ml) overnight at 4uC; rat IgG coating was used as a
negative control. After coating, filters were blocked with 2% BSA
in PBS for one hour. Subsequently, 2.5610
5 cerebellar granule
cells/ml were plated in culture medium into the upper chamber
and allowed to migrate through the pores onto the coated
undersurfaces at 37uCi naC O 2 incubator. After 24 hours, cells
from the inner surface of the insert were gently wiped out with
cotton-tipped swabs, and the inserts were fixed with 4%
paraformaldehyde for 30 minutes and stained with 0.2% crystal
violet solution in PBS for 30 minutes. After a final PBS washing,
the cells were examined under an inverted-TS100 microscope
(Nikon Singapore Pte Ltd, Singapore) to confirm proper
morphology, and the dye was extracted with 10% acetic acid in
PBS. The absorbance was measured at 570 nm using a microplate
reader (BioTek Instruments, Inc., Winooski, VT, USA). Dye levels
are directly proportional to the numbers of cells. Data are
presented as mean6S.E.M.
Cell survival assay (MTT assay)
1610
5 cerebellar granule cells were cultured in 96 well plates for
24 hours. Afterwards, 10 ml 5 mg/ml MTT solution was then
added and cells were cultured at 37uC for 4 hours. After washing
with PBS, 20% SDS in PBS was added to lyse the cells and dissolve
the dye crystals. The OD (absorbance) at 570 nm was determined
with an Elx800 universal microplate reader (BioTek Instruments)
and the percentage of surviving cells was calculated [25].
mRNA knockdown using short hairpin RNAs (shRNAs)
Cerebellar granule neurons from cerebella of 6- to 8-day-old
mice were isolated. (3–4)610
6 isolated neurons were combined
with 1 mg GFP plasmid, 1 mg respective shRNA vector or an
empty control vector (control group) and 100 ml neuron-specific
Nucleofector solution (Amaxa, Cologne, Germany), then trans-
ferred to an Amaxa-certified cuvette. Eletroporation was per-
formed according to the manufacturer’s Amaxa Nucleofection
protocol with the Amaxa Nucleofector
TM II device and mouse
neuron O-005 program [26]. After transfection cells were
transferred into culture dishes using the culture medium described
above. Twenty-four hours later, cells were fixed with 4%
paraformaldehyde. Subsequently, the cells were used for immu-
nocytochemical staining or neurite length measurement. For NIH-
3T3 cell transfection, 100 ml cell line-specific Nucleofector solution
(Amaxa) and NIH3T3 cells were mixed and transfected with the
Amaxa Nucleofector
TM II device as described for the transfection
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medium was used as described above.
Western blot analysis
Transfected NIH3T3 cells or cerebellar neurons were lysed with
RIPA buffer (1% NP-40, 0.5% sodium deoxycholate, 0.25% SDS,
0.1 5 M NaCl, 0.01 M sodium phosphate, 2 mM EDTA, 1 mM
NaF, 50 mM sodium fluoride, 1 mM sodium orthovanadate,
0.5 mM PMSF, 10 mg/ml aproptinin and leupeptin) [27]. Protein
concentration was determined by the Bio-Rad BCA assay.
Samples containing equal amounts of protein were resolved by
SDS-PAGE and transferred to polyvinylidene difluoride (PVDF)
membranes (Millipore, Billerica, MA, USA) followed by incuba-
tion with primary and secondary antibodies and chemiluminescent
detection using the ECL kit (GE Healthcare Bio-Sciences AB,
Uppsala, Sweden). The following antibodies were used in this
study: FUT9 and ST6Gal1 (Santa Cruz Biotechnology), PLCc1
(Cell Signaling Technology), and b-actin (Sigma).
Immunocytochemical staining
After transfection by electroporation [26], cultured cells were
grown on PLL-coated coverslips. After 24 hours in culture, cells
were fixed with 4% paraformaldehyde and permeabilized with
0.1% Triton X-100 for 30 minutes, after washing with PBS, fixed
and permeabilized cells were incubated with 5% BSA for 1 hour,
then incubated with the primary antibody for 2 hours and with the
secondary antibody for 1 hour. After drying, the cells were
mounted with Hard Set
TM fluorescence mounting medium
(Vector Laboratories, Inc. Burlingame, CA, USA) and observed
under a Leica microscope.
Data analysis
All data were expressed as mean6S.E.M. Statistical evaluations
were achieved by one-way analysis of variance and Student’s t test.
Differences were considered to be significant when p,0.05.
Results
Glycosylation patterns are changed on the surface of L1
+/y
and L1
2/y neurons
Since the cell adhesion molecule L1 is one of the important
carbohydrate-carrying molecules at the neuronal cell surface and
mediates interactions between other adhesion molecules in
nervous system, we hypothesized that L1 might also modulate
specific glycosylation patterns at neuronal cell surfaces. To test this
hypothesis, carbohydrate expression at the cell surface of neurons
isolated from L1
+/y (wt) and L1
2/y (ko) mice (the knockout of L1 is
shown in Fig. S1) was assayed by flow cytometry. Cerebellar
granule neurons from early postnatal brains were chosen for
analysis, since L1 is highly expressed during early postnatal
development and its expression peaks at postnatal day 7. A panel
of carbohydrate surface markers, including lectins and antibodies
against carbohydrates, such as the oligomannose-specific antibod-
ies L3, L4 and the Lewis
X specific antibody L5 were used (Fig. S2).
The quantitative results showed that the expression of a2,6-linked
sialic acid (recognized by Sambucus nigra lectin; SNA), a2,3-linked
sialic acid (recognized by Maackia amurensis lectin II; MAA), fucose
(recognized by Ulex europaeus agglutinin I; UEAI), and N-
acetyllactosamin in complex and hybrid sugars (recognized by
Datura stramonium lectin; DSL) as well as Lewis
X (recognized by
L5 antibody) were significantly downregulated in neurons of L1
2/y
mice compared with L1
+/y neurons (Fig. 1A). These results suggest
that L1 may modulate carbohydrate expression at neuronal cell
surfaces.
L1 regulates sialylation and fucosylation at cell surfaces
through L1–L1 trans-interactions
L1 at the cell surface is not only a donor, but also an acceptor of
certaincarbohydrates,therebyformingcomplexesbetweenapposing
partner cell surfaces through trans-interactions [13]. L1 on one cell
surface can interact homophilically with L1 on another cell surface
and these homophilic L1–L1 trans-interactions can be mimicked by
the treatment of L1 expressing cells with L1 antibodies [28]. To
further confirm that activation of L1 is involved in the modulation of
sialylation and fucosylation at cell surfaces, neurons isolated from
L1
+/yand L1
2/ymicewerecultured at a low densityand treated with
L1 antibodies for 24 hours. Then, using a panel of carbohydrate
surface markers, we performed flow cytometry analysis. Notably, the
expressionofcarbohydratesrecognizedbySNA,MAA,UEAI,DSL,
and L5 antibody were significantly upregulated in the L1
+/y
(Fig. 1Ba), but not in the L1
2/y (Fig. 1Bb) neurons after treatment
with L1 antibodies compared with rat IgG treatment. In particular,
the expression of a2,6-linked sialic acid was up-regulated 3-fold and
the expression of a2,3-linked sialic was 6-fold increased in L1treated
wild-type neurons, but not in L1-deficient neurons. The expression
patterns of carbohydrates regulated by L1 or L1 antibody are
summarized inFig.1C. The presenceof L1as well as treatment with
L1 antibodies had an impact on the expression of carbohydrates
recognized by SNA, MAA, UEAI, and L5 antibodies on the cell
surface of neurons. Both SNA and MAA lectins recognize terminal
sialic acids with different linkages. UEAI recognizes terminal fucose,
and the L5 antibody recognizes the fucose containing carbohydrate
Lewis
X. These results indicate that activation of L1 might regulate
the sialylation and fucosylation patterns of cell surfaces glycoproteins
and/or glycolipids.
L1 regulates the expression of the sialyltransferase,
ST6Gal1, and the fucosyltransferase, FUT9
To confirm that L1 is involved in the regulation of sialylation
and fucosylation of cell surfaces, we investigated whether
activation of L1 might alter the expression of specific sialyltrans-
ferases and/or fucosyltransferases. To identify the genes that
respond to L1 activation, a cDNA microarray analysis was
performed to compare L1 antibody-treated neurons with rat IgG-
treated neurons (neurons-L1Ab versus control neurons group;
Fig. 2A), and neurons isolated from the cerebellum of L1 ko mice
with neurons from the cerebellum of L1 wt mice (L1 ko versus L1
wt; Fig. 2A). Of 27 genes related to synthesis and hydrolysis of
carbohydrates examined, fucosyltransferase 9 (FUT9) was elevated
in the L1Ab-treated neurons versus the IgG-treated control
neurons (1.414-fold) and decreased in the L1 ko versus L1 wt
group (0.218-fold); b-galactoside-a2,6-sialyltransferase (ST6Gal1)
was elevated in the L1Ab-treated wt neurons, when compared to
the IgG-treated wt neurons (1.249-fold) and decreased in the L1 ko
versus L1 wt group (0.574-fold). Consistently, results of real-time
PCR and cDNA microarray showed that both ST6Gal1 and
FUT9 transcripts were significantly downregulated in L1
2/y
neurons versus L1
+/y neurons (Fig. 2A and Ba). Notably, L1
antibody treatment led to a two-fold increase in the mRNA
expression of UDP-Gal: bGlcNAc b1,4-galactosyltransferase
(B4GALT5) and xylosylprotein b1,4-galactosyltransferase
(B4GALT7) in wild-type neurons. In parallel, a 50% decrease in
FUCA2 transcript levels could be observed. However, expression
levels of the mRNAs encoding B4GALT5, B4GALT7 and
FUCA2 were not changed in L1
2/y neurons when compared
with L1
+/y neurons (Fig. 2A). Expression of the remaining genes
was not significantly altered in both groups. Moreover, we treated
both L1
2/y neurons and L1
+/y neurons with L1-Fc protein. Results
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levels of both ST6Gal1 and FUT9 were significantly upregulated
(3.8- and 1.3-fold, respectively) in L1-treated L1
+/y neurons versus
Fc-treated L1
+/y neurons, but there were no significant differences
in L1-treated versus Fc-treated L1
2/y neurons (Fig. 2Bb and c).
Thus, these results demonstrate that activation of L1 by antibody
treatment or homophilic interaction with L1-Fc upregulates the
expression of both ST6Gal1 and FUT9 in neurons.
Activated L1 promotes neurite outgrowth of neurons
isolated from L1
+/y, but not L1
2/y mice
In agreement with our previous study [28], we further confirmed
that L1 antibody treatment could mimic L1–L1 trans homophilic
interactions to promote neurite outgrowth through a trans-
interaction at cell surfaces (L1-Fc promoting neurite outgrowth is
shown in Fig. S3). Neurons isolated from L1
+/y and L1
2/y mice were
assayed for neurite outgrowth using different concentrations of L1
antibody 557 (Fig. 3Aa). Rat IgG treatment was used as a control.
The length of the longest neurite and the total length of all neurites
per cell were measured. Notably, L1 antibodies promoted neurite
outgrowth of neurons isolated from L1
+/y mice 1.5–2-fold, but not
outgrowth of L1
2/y neurons, both in terms of longest neurite
(Fig. 3Ab) and of total neurite (Fig. 3Ac) lengths. Immunostaining
resultconfirmed that the longestneurite is SMI312 positive(Fig. S4).
Activated L1 promotes cell migration and survival of
neurons
Moreover, to investigate whether L1-mediated neuronal
survival and migration can be mimicked by L1 antibody
treatment, we first determined the effect of L1 antibody 557 on
migration of cerebellar neurons and neuronal survival. To
investigate the role of L1 in cell migration, transwell membranes
were coated with L1 antibody 557, which only stimulates the cells
that express L1 at the cell surface. Transwell membranes were
coated with rat IgG as a control. Cell migration was significantly
increased by a factor of 1.5 in L1
+/y neurons triggered by L1
antibodies relative to rat IgG-treated control cells, but not in L1
2/y
neurons (Fig. 3B). To examine whether L1 antibody treatment
Figure 1. Glycosylation patterns on the cell surface of L1
+/y and L1
2/y neurons with and without treatment with anti-L1 antibodies.
A. Neurons isolated from L1
+/y (L1wt) and L1
2/y (L1ko) mice were subjected to flow cytometry analysis using a panel of carbohydrate surface markers,
including lectins and antibodies against carbohydrates. The quantitative result showed that the expression of carbohydrates recognized by SNA,
MAA, UEAI, and DSL as well as L5 antibody was significantly decreased in the neurons of L1
2/y mice versus L1
+/y mice. B. After treatment with anti-L1
antibodies, neurons isolated from L1
+/y (L1wt-L1Ab) and L1
2/y (L1ko-L1Ab) mice were assayed by flow cytometry using a panel of carbohydrate
surface markers, including lectins and antibodies against carbohydrates. The quantitative result showed that the expression of carbohydrates
recognized by SNA, MAA, UEAI, DSL, and L5 antibody was significantly increased in L1wt-L1Ab neurons versus neurons treated with rat IgG only
(‘‘L1wt’’). (a). The quantitative result showed that the expression of carbohydrates recognized by SNA, MAA, UEAI, DSL, and L5 antibody was no
significant different in L1ko-L1Ab neurons compared to L1
2/y neurons treated with rat IgG only (‘‘L1ko’’) (b). C. The expression patterns of
carbohydrates were compared between the L1
+/y neurons treated with anti-L1 antibodies and L1
+/y neurons treated with rat IgG (neuron-L1Ab/
neuron) and from neurons isolated from L1
2/y versus L1
+/y mice (L1ko/L1wt). L1 or L1 antibodies commonly regulated the sialylation and fucosylation
on the cell surface of neurons. *: p,0.05, and **: p,0.001 by Student’s test.
doi:10.1371/journal.pone.0003841.g001
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agreement with the pro-survival effect of L1 demonstrated in
our previous study [22], we showed that, after L1 antibody
treatment, neuronal survival was enhanced by 30% in neurons
isolated from L1
+/y, but not L1
2/y, mice (Fig. 3C). Rat IgG
treatment was used as a control. Cell cycle analysis was performed
as a complimentary experiment to further confirm the survival of
neurons. An increment in S and G2/M phases, but no apoptosis,
was observed in L1
+/+ neurons treated with L1Ab (Fig. S5).
ShRNA-mediated knockdown of FUT9 and ST6Gal1
blocks L1-induced neurite outgrowth, cell migration and
survival
To test the hypothesis that changes in sialylation and
fucosylation contribute to L1-mediated neurite outgrowth, cell
migration and survival, we performed the respective assays after
knockdown of FUT9 and ST6Gal1 by RNA interference. To this
end, we employed shRNAs of FUT9 and ST6Gal1, which could
significantly reduce the expression of either FUT9 or ST6Gal1 in
transfected NIH3T3 cells and neuron cells compared with empty
vector-transfected cells (Fig. 4A and B). Both longest and total
neurite lengths of L1 antibody treated neurons, but not untreated
neurons were significantly reduced (about 70%) after transfection
with either FUT9 shRNA or ST6Gal1 shRNA compared to
control vector-transfected cells (Fig. 4Ca and b). Moreover,
migration results also showed that the L1 antibody-induced
increases in migration of neurons stimulated with L1 antibody
were significantly decreased by 35% after transfection with FUT
shRNA and 60% after transfection with ST6Gal1 shRNA when
compared to mock-transfected neurons (Fig. 4D). Finally, survival
of L1 antibody-triggered neurons was significantly reduced after
Figure 2. The mRNA expression of ST6Gal1 and FUT9 is modulated by L1. A. cDNA microarray analysis was performed to investigate the
expression of genes involved in the synthesis and hydrolysis of the carbohydrates recognized by SNA, MAA, UEAI lectins and L5 antibodies by
comparing between L1 antibody-treated neurons and rat IgG-treated neurons (‘‘neurons-L1Ab’’ versus ‘‘neurons’’ group); and neurons isolated from
the cerebellum of L1
2/y mice versus L1
+/y mice (‘‘L1ko’’ versus ‘‘L1wt’’ group). Two microarrays per group were finished. The expression of
fucosyltransferase 9 (FUT9) was elevated in the ‘‘neurons-L1Ab’’ versus ‘‘neurons’’ group (1.414-fold) and decreased in the L1ko neurons versus L1wt
neurons group (0.218-fold), and b-galactoside-a2,6-sialyltransferase (ST6Gal1) expression was elevated in the ‘‘neurons-L1Ab’’ compared to the
‘‘neurons’’ group (1.249-fold) and decreased in the L1ko neurons versus L1wt neurons group (0.574-fold). B. To verify the results obtained by cDNA
microarray analysis, quantitative RT-real-time PCR was performed. The expression of ST6Gal1 and FUT9 mRNAs was significantly downregulated in
neurons isolated from L1
2/y (L1ko) versus L1
+/y (L1wt) mice (a) and upregulated in the L1-Fc-treated (‘‘L1wt-L1’’) versus Fc-treated (‘‘L1wt’’) group of
L1
+/y neurons (b and c). No significant differences were observed in L1-Fc-treated (‘‘L1ko-L1’’) versus Fc-treated (‘‘L1ko’’) L1
2/y neurons (b and c).
doi:10.1371/journal.pone.0003841.g002
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demonstrate that sialylation and fucosylation may also contribute
to the L1-induced modulation of neurite outgrowth, cell migration
and survival.
L1-induced increases in FUT9 and ST6Gal1 mRNA levels,
neurite outgrowth, cell migration and survival are
dependent on phospholipase Cc
To understand the mechanism by which L1 induces changes in
sialylation and fucosylation, we investigated the effects of inhibitors
of signal transduction pathways known to be activated by L1 on
FUT9 and ST6Gal1 mRNA levels. mRNA expression was assayed
by RT-real-time PCR. In neurons treated with L1 antibody, the
phospholipase Cc (PLCc) inhibitor U73122, the PKA inhibitor
KT5720 and the Erk inhibitor reduced both FUT9 and ST6Gal1
mRNA levels, with U73122 and Erk inhibitors having the
strongest effects (Fig. 5A). The PI3K inhibitor reduced FUT9
mRNA levels but not ST6Gal1 mRNA levels after L1 stimulation.
In contrast to this, inhibition of CDC25 had no effect on FUT9
and ST6Gal1 mRNA levels. PLCc, Cdc25, PI3K, Erk and PKA
inhibitors all decreased L1 antibody-induced neurite outgrowth in
cerebellar neurons (Fig. 5B), with the strongest effect being
produced by the PLCc inhibitor. PLCc, PI3K and Erk inhibitors
all reduced survival in L1 antibody-treated neurons, whereas the
Cdc25 and PKA inhibitors had no effect on survival (Fig. 5C).
Since Erk is a downstream element of PLCc signaling [13], the
aforementioned results imply that L1-induced increases in neurite
outgrowth may be dependent on the phospholipase Cc/Erk
signaling pathway as was previously shown, e.g. by Chen et al.
[29] and Loers et al. [22]. Furthermore, PLCc shRNA was used to
confirm these observations. PLCc shRNA was transfected into
NIH3T cells to confirm that it knocked down tPLCc expression
(Fig. 5Da). Notably, in cerebellar granule neurons treated with L1
antibody, PLCc shRNA reduced both FUT9 and ST6Gal1
mRNA levels compared with rat IgG treatment (Fig. 5Db).
shRNAs of PLCc significantly reduced the expression of PLCc in
transfected neuronal cells compared with empty vector-transfected
Figure 3. Activation of L1 promotes neurite outgrowth, cell migration and survival. A. Cerebellar granule neurons isolated from cerebella
of 6- to 8-day-old L1
+/y (L1wt) and L1
2/y (L1ko) mice were seeded on coverslips coated with PLL. After 1 hour in culture, L1 antibody 557 or rat IgG
(control) were added into the culture medium and the cells were cultured for a further 24 hours. a. Bright field micrographs of cerebellar neurons
isolated from L1
+/y (L1wt) and L1
2/y (L1ko) mice and cultured with different concentrations of L1 antibodies (L1Ab: 50, 100, and 200 mg/ml). b.
Longest neurite length. c. Total neurite length. B. To verify the role of L1 in cell migration, the undersurface of transwell membranes was coated with
the L1 antibody. In the control group, the undersurface of transwell membranes was coated with rat IgG. Relative numbers of cells transmigrating
through the membrane were determined by staining cells on the undersurface of the transwell membrane followed by cell lysis and measurement of
the absorbance value. Optical density measures of the dye level were directly proportional to numbers of migrated cells. Neuronal migration induced
by L1 antibody was significantly increased compared with neuronal migration induced by rat IgG in the neurons isolated from L1
+/y (L1wt) mice (O.D.:
0.29460.024, 0.46960.056, respectively), but not L1
2/y (L1ko) mice (O.D.: 0.24860.024, 0.23860.033, respectively). Photomicrographs illustrate the
migrated cells on the undersurface of the membrane (a). Quantitative measurement results of the optical density of the dye recovered by cell lysis (b).
C. To investigate the role of L1 in cell survival, MTT analysis was performed. After anti-L1 antibody (L1Ab) treatment (white bars), cell survival was
significantly enhanced in the neurons isolated from L1
+/y (L1wt) mice (O.D.: 0.11960.0047, 0.14260.0055, respectively), but not L1
2/y (L1ko) mice
(O.D.: 0.093860.0025, 0.091960.0046, respectively). Rat IgG treatment was used as control. *: p,0.05, by Student’s test.
doi:10.1371/journal.pone.0003841.g003
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shRNA reduced neurite outgrowth, cell migration and survival
when compared with control vector transfection (Fig. 5F, G and
H). Thus, taken together these data suggest that L1 is able to
regulate sialylation and fucosylation to modulate cell function via a
PLCc dependent pathway.
Discussion
In our study, we demonstrate that activation of the cell adhesion
molecule L1 leads to increased mRNA levels of a brain-relevant
sialyltransferase, namely ST6Gal1, and a fucosyltransferase,
namely FUT9. This regulation may contribute to the observed
changes in sialylation and fucosylation of surface glycoproteins
and/or glycolipids in L1-deficient mouse brains. Activation of L1
signal transduction pathways enhances cell survival, migration and
neurite outgrowth, which can be blocked by shRNA-mediated
knockdown of ST6Gal1 and FUT9. A PLCc-dependent pathway
contributes to the L1-induced increases in expression of the
sialyltransferase and fucosyltransferase and to the L1-mediated
neurite outgrowth and cell survival.
The central dogma of molecular biology has been revised to
include glycosylation or the attachment of glycans or carbohy-
drates to proteins or lipids, which provides for the needed
functional diversity to generate extensive phenotypes from a
limited genotype [1]. As glycosylation is not under the direct
control of the genome, it is not possible to predict a cell’s glycan
repertoire from analyses of genomic DNA sequences. Under-
standing of the importance of glycan function in the nervous and
immune systems during development has only recently emerged.
Relatively little attention has been paid to the regulation of their
expression till now, probably because of their intricate modes of
synthesis. Here, we have first shown that the expression of both
sialic acids and fucose is significantly reduced at the cell surfaces of
L1
2/y neurons, indicating that L1 is able to modulate both
sialylation and fucosylation of glycoproteins and/or glycolipids at
the surface of neurons. Consistently, we have demonstrated that
mRNA levels of the sialyltransferase ST6Gal1 and the fucosyl-
Figure 4. shRNAs of FUT9 and ST6Gal1 reduce L1 promoted neurite outgrowth, cell migration and survival. A. NIH3T3 cells were co-
transfected with GFP plasmid plus empty vector (control) or shRNA of FUT9 or ST6Gal1 by electroporation. 24 hours later, cells were lysed and total
protein was obtained. Western blotting was used to detect the expression of FUT9 and ST6Gal1. B. Neurons were dissected from the cerebellum of 6-
to 8-day-old mice. Neurons were co-transfected with GFP plasmid plus shRNA of FUT9 or ST6Gal1 shRNA by electroporation and seeded on
coverslips. GFP plasmid plus empty vector transfection was used as control. After 24 hours in culture, cells were fixed then stained with anti-FUT9 or
anti-ST6Gal1 antibodies. (a): Immunocytochemistry for FUT9 or ST6Gal1 (red) in transfected neurons (green) indicated the knockdown efficiency,
arrows indicate the same transfected cells in the upper and lower panels. (b): The co-transfection ratios of GFP and shRNA of FUT9 or ST6Gal1 to GFP
and empty vector were quantified. C. Neurons were co-transfected with GFP plasmid plus empty vector (control) or shRNA of FUT9 or ST6Gal1, and
seeded on coverslips coated with L1 antibody (L1Ab) or rat IgG. After 24 hours in culture, longest neurite length (a) and total neurite length (b) were
measured. D. Cell migration assay was performed in L1antibody-treated neurons (Neurons-L1Ab) co-transfected with GFP plasmid plus empty vector
(control) or shRNA of FUT9 or ST6Gal1. The percentage of cell migration was calculated by counting and comparing the number of green neurons on
the upper surface and the undersurface of transwells. E. MTT analysis of L1antibody-treated neurons (Neurons-L1Ab) was performed after co-
transfection with GFP plasmid plus empty vector (control, O.D.: 0.12260.0054) or shRNA of FUT9 (O.D.: 0.087260.0011) or ST6Gal1 (O.D.:
0.085960.012). *: p,0.05; **: p,0.001, by Student’s test, empty plasmid transfection neurons were controls.
doi:10.1371/journal.pone.0003841.g004
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2/y
neurons compared with the levels in L1
+/y neurons. Moreover,
we have shown that stimulation with the L1 antibody 557, which
can functionally mimic a L1–L1 trans-interaction as described for a
scFv antibody [28] recognizing the same domain within the L1
molecule as the 557 antibody, and the stimulation with L1-Fc
significantly increased the mRNA levels of the sialyltransferase
ST6Gal1 and the fucosyltransferase FUT9 on the cell surfaces of
Figure 5. L1 influences FUT9 and ST6Gal1 mRNA levels, neurite outgrowth, cell migration and cell survival via various intracellular
signaling mediators. A. Cerebellar granule neurons isolated from the cerebella of wild type mice (6- to 8-day-old) were seeded on coverslips
coated with PLL and PLL plus L1 antibodies (neurons-L1Ab). After 1 hour in culture, inhibitors of PLCc (U73122, 10.5 mM), CDC25 phosphatase
(CDC25 inhibitor II, 1.05 mM), PI3K (LY294002, 16.5 mM), Erk (Erk activation inhibitor I, 50 mM) or PKA (KT5720, 280 nM) were added into the culture
medium and the cells were cultured for a further 24 hours. Levels of FUT9 mRNA (a) and ST6Gal1 mRNA (b) were quantified by RT-real-time PCR. B.
Neurons were seeded on coverslips coated with PLL plus L1 antibodies (L1Ab). Rat IgG coating was used as control. After treatment with the
inhibitors of signal transduction pathways listed in A, longest neurite length (a) and total neurite length (b) were measured. C. Neurons were seeded
on coverslips coated with PLL plus L1 antibodies (neurons-L1Ab). After treatment with the inhibitors of signal transduction pathways, cell survival was
quantified by MTT assay (O.D.: 0.13960.0065, 0.053860.0027, 0.11160.023, 0.090560.0018, 0.076960.0035 and 0.14860.0089, respectively). D.
NIH3T3 cells were co-transfected with GFP plasmid plus empty vector (control) or shRNA for PLCc by electroporation. Twenty four hours later, cells
were lysed with RIPA buffer and total protein was obtained. Western blot was used to detect the expression of PLCc (a). The expression levels of
ST6Gal1 and FUT9 mRNAs were detected with real-time PCR after transfected neurons with PLCc shRNAs or empty vector (control) (b). E. Neurons
were co-transfected with GFP plasmid plus empty vector (control) or shRNA for PLCc by electroporation and seeded on coverslips. After 24 hours in
culture, cells were fixed then stained with anti-PLCc antibodies. (a): Immunocytochemistry for PLCc (red) in transfected precursors (green) indicated
the knockdown efficiency. (b): The co-transfection ratio of GFP and PLCc shRNA to GFP and empty vector were quantified. F. Neurons were co-
transfected with GFP plasmid plus empty vector (control) or shRNA for PLCc and seeded on coverslips coated with L1 antibody (L1Ab), rat IgG
coating was used as control. After 24 hours in culture, the length of the longest neurite length (a) and total neurite length (b) were measured. G. Cell
migration assay was performed in L1 antibody-treated neurons (neurons-L1Ab) co-transfected with GFP plasmid plus empty vector (control) or
shRNA for PLCc. The percentage of cell migration was calculated by counting and comparing the number of green neurons on the upper and lower
surface of the transwells. H. MTT analysis of L1ab-treated neurons (neurons-L1Ab) was performed after co-transfection with GFP plasmid plus empty
vector (control, O.D.: 0.12560.0054) or shRNA for PLCc (O.D.: 0.099360.0035). *: p,0.05; **: p,0.001, by Student’s test, empty plasmid transfection
neurons were controls.
doi:10.1371/journal.pone.0003841.g005
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+/y, but not L1
2/y
mice. This finding indicates that L1–L1 interaction modulated the
sialylation and fucosylation on cell surface.
In the nervous system, the diversity of cell–cell interactions is
largely mediated by glycans and glycans appear to have been
pushed to an even higher degree of sophistication. Some very
unusual glycans are pivotal not only during nervous system
development and regeneration but also in synaptic plasticity
underlying learning and memory [7]. Additionally, glycans
contribute to the folding and conformational stability of many
proteins [30–33] and serve as ligands for glycan-binding proteins
that mediate cell trafficking, cell adhesion, and cell signaling [34–
38]. In agreement with our previous studies [17,28], we have
shown that antibodies to the cell recognition molecule L1, which
mimic a L1–L1 trans-interaction, enhance neurite outgrowth.
Importantly, the anti-L1-antibody-mediated promotion of neurite
outgrowth occurs only in neurons isolated from wild-type, but not
L1 knockout mice. Since sialylation and fucosylation are enhanced
at cell surfaces of the anti-L1 antibody-treated neurons, the specific
pattern of glycosylation induced by L1 may also be an important
factor in promoting neurite outgrowth and neuronal differentia-
tion. Furthermore, due to the fact that L1 stimulation can
modulate sialylation and fucosylation, we have proposed that the
L1-induced specific glycosylation pattern may not only influence
neurite outgrowth but also contribute, at least partially, to
neuronal survival and migration. In agreement with this notion,
we have confirmed that L1 promotes cell survival and migration
through the L1–L1 trans-interaction mimicked by application of
anti-L1 antibody 557, which can be blocked by shRNAs of
transferases of sialylation and fucosylation. Thus, these observa-
tions demonstrate that L1 may be involved in neuronal survival
and migration through its role in modulating glycosylation on cell
surface for its specific neuronal functions.
The NCAM and L1 family of adhesion molecules are thought to
trigger neurite outgrowth, axonal growth or cell migration by
activation of a number of signal transduction pathways, including
PLCc-, PI3K-, Erk- and PKA-dependent pathways [7,39]. We
found that both a PLCc inhibitor and knockdown of PLCc by
shRNA reduced FUT9 and ST6Gal1 mRNA levels in L1
antibody-treated neurons. Although inhibitors of other signal
transduction pathways also had effects on L1-induced neurite
outgrowth and cell survival, inhibition of PLCc consistently
resulted in strong inhibition of neurite outgrowth and cell survival
in L1 antibody-treated neurons. This suggests that L1 may
regulate both sialylation and fucosylation in relation to cell
function via a PLCc-dependent pathway in neurons. Inhibition of
PI3K or Erk also reduced L1 antibody-mediated cell survival, as
described previously for stimulation with L1-Fc [22]. This may be
consistent with the involvement of Erk downstream of PLCc, but
would also be consistent with additional involvement of the Src–
PI3K–Erk signaling pathway [7].
During the last decade, increasing evidence has suggested that
carbohydrate-carrying molecules in the nervous system have
important roles during development, regeneration and synaptic
plasticity [7]. In humans, defects in the assembly or processing of
N-glycans results in a broad clinical spectrum of inherited
disorders, which in most cases show psychomotor and mental
retardation or other neurological dysfunctions, such as epilepsy,
ataxia, microcephalus, cerebral and cerebellar atrophy, abnormal
eye movements and decreased nerve conduction velocity [40]. A
successful example of the therapeutic use of a glycan for the
treatment of a clinical defect is the oral administration of mannose
for the treatment of congenital mannosyl transferase deficiency, a
congenital metabolic disease affecting multiple systems, including
the nervous system of infants [41]. Here, we have demonstrated
that L1 could modulate fucosylation and sialylation of cell surface
proteins and/or lipids by regulating the expression of fucosyl-
transferase 9 and b-galactoside-a2,6-sialyltransferase, which in
turn regulates cell survival and migration in neurons. Thus, an
important insight of this study is that a distinct glycosylation
pattern on the cell surface could be regulated by a specific genetic
modulation, which could be applied to manipulate cell-cell
communication in development or disease, leading to greater
precision and specificity in drug targeting.
Supporting Information
Figure S1 Western blot result. Cerebellar granule cells from
L1+/y and L12/y mice were lysed and total protein was
obtained. Western blotting was used to detect the expression of
L1. There was a band at around 200 kDa for the L1+/y neurons
and no band for the L12/y neurons detectable, indicating that L1
is completely knocked out from the L12/y mice.
Found at: doi:10.1371/journal.pone.0003841.s001 (1.85 MB TIF)
Figure S2 Glycosylation patterns on the cell surface of L1+/y
neurons, L12/y neurons, and neurons of L1+/y and L12/y mice
treated with anti-L1 antibodies. Neurons isolated from L1+/y
(L1wt) and L12/y (L1ko) mice and neurons isolated from L1+/y
and L12/y mice treated with anti-L1 antibodies (L1wt-L1Ab and
L1ko-L1Ab respectively) were subjected to flow cytometry analysis
using a panel of carbohydrate surface markers, including lectins
and antibodies against carbohydrates. In the flow cytometry
histograms, the filled green areas show the number of unstained
cells and the areas outlined in red represent cells binding to various
lectins (SNA, MAA, UEAI, DSL, and JAC) and carbohydrates
antibody (L5). A. Results of neurons isolated from L1+/y (L1wt)
and L12/y (L1ko) mice. B. Results of neurons from L1+/y and
L12/y mice treated with anti-L1 antibodies (L1wt-L1Ab and
L1ko-L1Ab respectively).
Found at: doi:10.1371/journal.pone.0003841.s002 (10.39 MB
TIF)
Figure S3 L1 promotes neurite outgrowth. Cerebellar granule
neurons were isolated from cerebellum of 6- to 8-day-old mice and
seeded on coverslips coated with PLL. After 1 hour in culture, L1-
Fc fusion protein or Fc (control) was added into the culture
medium. The cells were cultured for a further 24 hours and
pictures were taken. Neurite length was measured. Left: Longest
neurite length. Right: Total neurite length. The results indicate
that L1 significantly promotes neurite outgrowth. Data represent
mean6SEM of three independent experiments. * p,0.05
significant difference from Fc.
Found at: doi:10.1371/journal.pone.0003841.s003 (4.35 MB TIF)
Figure S4 Immunostaining result. Neurons were dissected from
the cerebellum of 6- to 8-day-old mice. After 24 hours in culture,
cells were fixed and then incubated with anti-SMI-312 antibodies.
Immunocytochemistry showed that SMI-312 was positive in
neurons. SMI31Ab recognizes the axonal compartment, so this
indicates that the measured longest neurites are actually axons.
Found at: doi:10.1371/journal.pone.0003841.s004 (7.25 MB TIF)
Figure S5 Cell cycle analysis of neuron cell survival. Cell cycle
analysis using propidium iodide (PI) staining was performed as a
complimentary experiment to confirm the cell survival. A
significant increase in cell survival was observed in L1Ab treated
L1+/y neurons (S+G2/M=34.96%, B) compared with L1+/y
neurons treated with rat IgG (control: S+G2/M=19.23%, A). No
such increase was observed in L12/y neurons treated with L1Ab
(S+G2/M=13.42%, D) compared with L12/y neurons treated
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detected in the cell cultures.
Found at: doi:10.1371/journal.pone.0003841.s005 (6.91 MB TIF)
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